![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 3, 2062-2068, January 19, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Phaseolin Promoter by
Phosphatase or Protein Synthesis Inhibitors*
,
From the Institute of Developmental and Molecular Biology and
Department of Biology, Texas A & M University, College
Station, Texas 77843-3155
The promoter for the phaseolin (phas)
bean seed protein gene adopts an inactive chromatin structure in leaves
of transgenic tobacco. This repressive architecture, which confers
stringent spatial regulation, is disrupted upon transcriptional
activation during embryogenesis in a process that requires the presence
of both a transcription factor (PvALF) and abscisic acid (ABA). Toward determining the need for de novo synthesis of proteins
other than PvALF in transcriptional activation we explored the effect
of several eukaryotic protein synthesis inhibitors. Surprisingly, cycloheximide (CHX), emetine, and verrucarin A were able to induce transcription from the phas promoter in tobacco and bean
leaf tissue in the absence of either PvALF or ABA. This induction was decreased by the replication inhibitors hydroxyurea and aphidicolin but
not by genistein or mimosine. Since protein phosphatases and kinases are essential components of the ABA signal transduction pathway, it is conceivable that CHX is also capable of inducing phosphorylation of proteins usually involved in ABA-mediated
activation. Interestingly, okadaic acid, an inhibitor of
serine/threonine phosphatase, also strongly activated transcription
from the phas promoter. In contrast, the protein synthesis
inhibitors anisomycin and puromycin did not activate transcription from
the phas promoter, nor did the tyrosine phosphatase
inhibitors phenylarsine oxide and sodium orthovanadate. These discrete
but different results on transcriptional activation may reflect
specific modes of action of the inhibitors, or they may reflect
differential interactions of the inhibitors or of downstream events
resulting from inhibitor activity with presently unknown components of
the transcriptional activation system.
Present address: Sangamo Biosciences Inc., 501 Canal Blvd., Suite
A100, Richmond, CA 94804.
§
To whom correspondence should be addressed. Fax: 979-862-4098;
E-mail: tim@idmb.tamu.edu.
This article has been cited by other articles:
![]() |
M. B. Chandrasekharan, G. Li, K. J. Bishop, and T. C. Hall S Phase Progression Is Required for Transcriptional Activation of the {beta}-Phaseolin Promoter J. Biol. Chem., November 14, 2003; 278(46): 45397 - 45405. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |